SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkchris who wrote (43981)12/2/2005 10:41:34 AM
From: Stuki  Read Replies (1) of 120413
 
RPBIF I wonder if the "nonexclusive license" part of the agreement with Roche is holding the price down?

From July 26 pr:

Agreement Expands Availability of Cardiac Markers that Aid Early on the
Spot Diagnosis and Thus Improve Treatment

BASEL, Switzerland and VANCOUVER, Canada, July 26 /CNW/ - Roche
Diagnostics and Response Biomedical (TSX-V: RBM, OTCBB: RPBIF), announced
today that Response Biomedical has been granted a nonexclusive license under
patent rights of Roche Diagnostics to commercialize NT-proBNP (N-terminal
prohormone brain natriuretic peptide), a key cardiac marker for a broad array
of cardiovascular conditions. The agreement expands availability of this key
cardiovascular marker that aids in diagnosis of heart failure and risk
stratification of patients with acute coronary syndrome or heart failure.
As part of the agreement, Response Biomedical also received an option to
commercialize Troponin T (cardiac marker for myocardial infarction) for use
with its RAMP System for the Point of Care market segment. The availability of
test results for the diagnostic assessment of patients with suspected cardiac
diseases - like myocardial infarction and heart failure - within minutes is
vital, especially in critical care situations when every minute counts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News